Steffen Lang
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
-
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Protein Structure and Dynamics
- Chemical Synthesis and Analysis
Papers in
-
- Protein Structure and Dynamics 5
- Protein Degradation and Inhibitors 3
-
- Asymmetric Synthesis and Catalysis 2
- Co-authors
- Chris Abell (8 shared papers)P. Sledz (7 shared papers)Christopher J. Stubbs (6 shared papers)Ellene H. Mashalidis (1 shared paper)Inge Van Molle (1 shared paper)Alessio Ciulli (1 shared paper)Dennis L. Buckley (1 shared paper)Ernest C. So (1 shared paper)
- Journals
- Angewandte Chemie International Edition (4 papers)Journal of Pharmaceutical Sciences (2 papers)Nature Protocols (1 paper)Tetrahedron Letters (1 paper)Journal of Pharmacy and Pharmacology (1 paper)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Steffen Lang
18 papers receiving 682 citations
Peers
Comparison fields: 5 of 86
- Pharmaceutical Science 96
- Molecular Biology 490
- Computational Theory and Mathematics 120
- Cell Biology 96
- Oncology 144
Countries citing papers authored by Steffen Lang
This map shows the geographic impact of Steffen Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Lang more than expected).
Fields of papers citing papers by Steffen Lang
This network shows the impact of papers produced by Steffen Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Lang. The network helps show where Steffen Lang may publish in the future.
Co-authors
The 25 scholars most cited alongside Steffen Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 168 | |
| 2 | 2013 | 108 | |
| 3 | 2012 | 71 | |
| 4 | 2000 | 63 | |
| 5 | 2011 | 62 | |
| 6 | 1998 | 36 | |
| 7 | 1997 | 34 | |
| 8 | 2012 | 31 | |
| 9 | 2016 | 30 | |
| 10 | 1996 | 30 | |
| 11 | 2005 | 19 | |
| 12 | 2008 | 16 | |
| 13 | 2015 | 13 | |
| 14 | 2012 | 11 | |
| 15 | 2011 | 8 | |
| 16 | 2008 | 6 | |
| 17 | 2008 | 6 | |
| 18 | 2012 | 6 | |
| 19 | 2009 | 0 |
About Steffen Lang
Steffen Lang is a scholar working on Molecular Biology, Organic Chemistry, Cell Biology, Pharmaceutical Science and Materials Chemistry, having authored 19 papers that have together received 718 indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (5 papers), Protein Structure and Dynamics (5 papers), Protein Degradation and Inhibitors (3 papers), Enzyme Structure and Function (3 papers), Traditional and Medicinal Uses of Annonaceae (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers) and Asymmetric Synthesis and Catalysis (2 papers). The work is most often cited by research in Pharmaceutical Science (96 citations), Molecular Biology (490 citations), Computational Theory and Mathematics (120 citations), Cell Biology (96 citations) and Oncology (144 citations). Steffen Lang has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Chris Abell, P. Sledz, Christopher J. Stubbs, Ellene H. Mashalidis, Inge Van Molle, Alessio Ciulli, Dennis L. Buckley, Ernest C. So, Hans P. Merkle and Andreas Thomann. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Pharmaceutical Sciences, Nature Protocols, Tetrahedron Letters and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.